Vaccine-acquired rotavirus in infants with severe combined immunodeficiency

Niraj C. Patel; Paula M. Hertel; Mary K. Estes; Maite De La Morena; Ann M. Petru; Lenora M. Noroski; Paula A. Revell; I. Celine Hanson; Mary E. Paul; Howard M. Rosenblatt; Stuart L. Abramson

doi:10.1056/NEJMoa0904485

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency

Niraj C. Patel, Paula M. Hertel, Mary K. Estes, Maite De La Morena, Ann M. Petru, Lenora M. Noroski, Paula A. Revell, I. Celine Hanson, Mary E. Paul, Howard M. Rosenblatt, Stuart L. Abramson

Research output: Contribution to journal › Article › peer-review

181 Scopus citations

Abstract

Live pentavalent human-bovine reassortant rotavirus vaccine is recommended in the United States for routine immunization of infants. We describe three infants, two with failure to thrive, who had dehydration and diarrhea within 1 month after their first or second rotavirus immunization and subsequently received a diagnosis of severe combined immunodeficiency. Rotavirus was detected, by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, in stool specimens obtained from all three infants, and gene-sequence analysis revealed the presence of vaccine rotavirus. These infections raise concerns regarding the safety of rotavirus vaccine in severely immunocompromised patients.

Original language	English (US)
Pages (from-to)	314-319
Number of pages	6
Journal	New England Journal of Medicine
Volume	362
Issue number	4
DOIs	https://doi.org/10.1056/NEJMoa0904485
State	Published - Jan 28 2010

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMoa0904485

Cite this

@article{7e044f377f5d436a897c4c975a875e57,

title = "Vaccine-acquired rotavirus in infants with severe combined immunodeficiency",

abstract = "Live pentavalent human-bovine reassortant rotavirus vaccine is recommended in the United States for routine immunization of infants. We describe three infants, two with failure to thrive, who had dehydration and diarrhea within 1 month after their first or second rotavirus immunization and subsequently received a diagnosis of severe combined immunodeficiency. Rotavirus was detected, by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, in stool specimens obtained from all three infants, and gene-sequence analysis revealed the presence of vaccine rotavirus. These infections raise concerns regarding the safety of rotavirus vaccine in severely immunocompromised patients.",

author = "Patel, {Niraj C.} and Hertel, {Paula M.} and Estes, {Mary K.} and {De La Morena}, Maite and Petru, {Ann M.} and Noroski, {Lenora M.} and Revell, {Paula A.} and Hanson, {I. Celine} and Paul, {Mary E.} and Rosenblatt, {Howard M.} and Abramson, {Stuart L.}",

year = "2010",

month = jan,

day = "28",

doi = "10.1056/NEJMoa0904485",

language = "English (US)",

volume = "362",

pages = "314--319",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "4",

}

TY - JOUR

T1 - Vaccine-acquired rotavirus in infants with severe combined immunodeficiency

AU - Patel, Niraj C.

AU - Hertel, Paula M.

AU - Estes, Mary K.

AU - De La Morena, Maite

AU - Petru, Ann M.

AU - Noroski, Lenora M.

AU - Revell, Paula A.

AU - Hanson, I. Celine

AU - Paul, Mary E.

AU - Rosenblatt, Howard M.

AU - Abramson, Stuart L.

PY - 2010/1/28

Y1 - 2010/1/28

N2 - Live pentavalent human-bovine reassortant rotavirus vaccine is recommended in the United States for routine immunization of infants. We describe three infants, two with failure to thrive, who had dehydration and diarrhea within 1 month after their first or second rotavirus immunization and subsequently received a diagnosis of severe combined immunodeficiency. Rotavirus was detected, by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, in stool specimens obtained from all three infants, and gene-sequence analysis revealed the presence of vaccine rotavirus. These infections raise concerns regarding the safety of rotavirus vaccine in severely immunocompromised patients.

AB - Live pentavalent human-bovine reassortant rotavirus vaccine is recommended in the United States for routine immunization of infants. We describe three infants, two with failure to thrive, who had dehydration and diarrhea within 1 month after their first or second rotavirus immunization and subsequently received a diagnosis of severe combined immunodeficiency. Rotavirus was detected, by means of reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay, in stool specimens obtained from all three infants, and gene-sequence analysis revealed the presence of vaccine rotavirus. These infections raise concerns regarding the safety of rotavirus vaccine in severely immunocompromised patients.

UR - http://www.scopus.com/inward/record.url?scp=75449116116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75449116116&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa0904485

DO - 10.1056/NEJMoa0904485

M3 - Article

C2 - 20107217

AN - SCOPUS:75449116116

SN - 0028-4793

VL - 362

SP - 314

EP - 319

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 4

ER -

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this